The hepatitis A virus (HAV) is primarily transmitted by the fecal-oral route, either by person-to-person contact or consumption of contaminated food or water. It has an incubation period of about 28 days (range: 15–50 days). Among adults the infection is typically symptomatic with fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. HAV infection is self-limiting and does not result in chronic liver disease.47
There are two inactivated hepatitis A whole-virus vaccines (Vaqta, Havrix) and a combination hepatitis A and B vaccine (Twinrix) available (Table 10). Twinrix contains the same hepatitis A component as Havrix, but half the dose. Hepatitis A vaccination is recommended for adults with chronic liver disease, illicit drug users, and those at risk of healthcare-associated exposure. Vaccination with Vaqta and Havrix consists of 2 doses; vaccination with Twinrix requires 3 doses.
|Pre- and post-exposure||
2 IM doses at 0 and 6-18 months
2 IM doses at 0 and 6-12 months
|Erythema, edema, pain at injection site; malaise, fever, and fatigue may occur.|
|Twinrix||Preexposure||3 IM doses at 0, 1, and 6 months||As above plus anaphylaxis in persons with history of allergic reaction to baker’s yeast.|
Passive Immunization: Immune Globulin
Immune globulin is available for short-term pre- and post-exposure protection (approximately 3 months) against hepatitis A. Immune globulin must be administered within 2 weeks after exposure for maximum protection.6
Your session is about to expire. Do you want to continue logged in?
WARNING! You did not finish creating your certificate. Please click CONTINUE below to return to your previous page to complete the process. Failure to complete ALL the steps will result in a loss of this test score, and you will not receive credit for this course.